TY  - JOUR
AU  - Teira, Ramón
AU  - Diaz-Cuervo, Helena
AU  - Aragão, Filipa
AU  - Marguet, Sophie
AU  - de la Fuente, Belén
AU  - Muñoz, Maria Jose
AU  - Abdulghani, Nadia
AU  - Ribera, Esteban
AU  - Domingo, Pere
AU  - Deig, Elisabeth
AU  - Peraire, Joaquim
AU  - Roca, Bernardino
AU  - Montero, Marta
AU  - Galindo, Maria José
AU  - Romero, Alberto
AU  - Espinosa, Nuria
AU  - Lozano, Fernando
AU  - Merino, María Dolores
AU  - Martínez, Elisa
AU  - Geijo, Paloma
AU  - Estrada, Vicente
AU  - García, Josefina
AU  - Sepúlveda, M Antonia
AU  - Berenguer, Juan
PY  - 2021
DO  - 10.1371/journal.pone.0249515
UR  - http://hdl.handle.net/10668/17546
T2  - PloS one
AB  - Since 1996, the standard of care (SOC) therapy for HIV treatment has consisted of a backbone of two nucleoside analogue reverse transcriptase inhibitors (NRTI) paired with a third agent. Use of two-drug combinations (2DC) has been considered for...
LA  - en
KW  - Anti-HIV Agents
KW  - Drug Combinations
KW  - Female
KW  - HIV Infections
KW  - HIV-1
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Retrospective Studies
KW  - Reverse Transcriptase Inhibitors
KW  - Standard of Care
KW  - Viral Load
TI  - Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV.
TY  - research article
VL  - 16
ER  -